The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Actilyse 20mg Powder and Solvent for Solution for Injection and Infusion - PA0775/011/002
- Clonazepam Rosemont 0.5mg/5ml Oral Solution - PA23081/009/001
- Lustral 100mg Film Coated Tablets - PA23055/001/002
- Meropenem Aurobindo 1g Powder for Solution for Injection or Infusion - PA1445/014/002
- Methylthioninium Chloride Proveblue 5mg/ml Solution for Injection - EU/1/11/682/001
- Minims Cyclopentolate Hydrochloride 1% w/v Eye Drops- PA23259/011/001
- Paracetamol 500mg Film Coated Tablets (100 pack) - PA2315/065/003
- Tritace 10mg Tablets - PA0540/084/008
- Zithromax 250mg Capsules - PA0822/191/001
- Zithromax 200mg/5ml Powder for Oral Suspension - PA0822/191/002
The following shortages have been resolved and supply has resumed to the Irish market:
- Abstral 300mcg Sublingual Tablets - PA2288/004/004
- Concerta XL 18mg Prolonged Release Tablets - PA22612/002/001
- Distaclor LA 375 mg Prolonged Release Tablets - PA1226/001/004
- Fucibet Lipid 20mg/g + 1mg/g Cream - PA0046/040/002
- Kentera Transdermal Patches - EU/1/03/270/001-2
- Rapifen 500mcg/ml Solution for Injection or Infusion - PA22583/001/001
- Tecentriq 1200mg Concentrate for Solution for Infusion - EU/1/17/1220/001
- Trileptal 150mg Film Coated Tablets - PA0896/033/001
- Xarelto 1mg/ml Granules for Oral Suspension (100ml bottle) - EU/1/08/472/050
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.